<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-OPC-14005553</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2014-11-28</date_registration>
      <primary_sponsor>The Affiliated Drum Tower Hospital of Nanjing University Medical School</primary_sponsor>
      <public_title>Clinical study of the treatment of infertility caused by severe intrauterine adhesions by collagen scaffold loaded with umbilical cord blood-derived mesenchymal stem cells</public_title>
      <acronym />
      <scientific_title>Clinical study of the treatment of infertility caused by severe intrauterine adhesions by collagen scaffold loaded with umbilical cord blood-derived mesenchymal stem cells</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2014-11-07</date_enrolment>
      <type_enrolment />
      <target_size>collagen scaffold loaded with umbilical cord blood  :20;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=9934</url>
      <study_type>Observational study</study_type>
      <study_design>Case series</study_design>
      <phase>I (Phase I study)</phase>
      <hc_freetext>infertility caused by severe intrauterine adhesions</hc_freetext>
      <i_freetext>collagen scaffold loaded with umbilical cord blood  :hysteroscopy adhesiolysis followed by collagen scaffold loaded with umbilical cord blood-derived mesenchymal stem cells treatment ;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Xin-an Li</firstname>
        <middlename />
        <lastname />
        <address>Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, 321 Zhongshan Road, Nanjing, Jiangsu, China</address>
        <city />
        <country1 />
        <zip>210008</zip>
        <telephone>+86 15905197916</telephone>
        <email>li_xinan@126.com</email>
        <affiliation>The Affiliated Drum Tower Hospital of Nanjing University Medical School</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Yali Hu</firstname>
        <middlename />
        <lastname />
        <address>Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, 321 Zhongshan Road, Nanjing, Jiangsu, China</address>
        <city />
        <country1 />
        <zip>210008</zip>
        <telephone>+86 13951846008</telephone>
        <email>glyyhuyali@163.com</email>
        <affiliation />
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. patients with severe intrauterine adhesions or scarring of the endometrium for whom drugs and surgical interventions were ineffective;
2. Age: 22-45 years old;
3. who is willing to accept follow-up.</inclusion_criteria>
      <agemin>22</agemin>
      <agemax>45</agemax>
      <gender>Female</gender>
      <exclusion_criteria>1. Chromosome karyotype abnormalities;
2. Severe endometriosis; 
3. Severe adenomyosis;
4. Severe congenital uterine malformations;
5. Vaginitis and endometritis;
6. systemic diseases: hypertension, diabetes, and so on;
7. Contraindications to pregnancy;
8. Contraindications to hormone replacement therapy;
9. Medical history of pelvic tumors or receiving pelvic radiotherapy;
10. Unable to adhere to the hospital examination and follow-up, or carrying on other treatment during follow-up period.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Menstruation;Endometrial thickness and blood flow;Endometrial recovery status;Conception;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Prenatal care;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Strategic Priority Research Program of Chinese Academy of Science</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2014-11-25</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>